8-KEarnings & ResultsExhibits & Filings

VERTEX PHARMACEUTICALS INC / MA 8-K Report, Financial Results (Aug 5, 2009)

Filed August 5, 2009For Securities:VRTX

Summary

Vertex Pharmaceuticals Incorporated (VRTX) filed an 8-K report on August 5, 2009, to announce its financial results for the quarter ended June 30, 2009. This filing primarily serves to incorporate by reference a press release containing these results, which was issued on the same date. Investors seeking detailed financial performance, operational updates, and forward-looking statements should refer to the press release (Exhibit 99.1) attached to this filing. The core purpose of this 8-K is to formally disclose the company's financial standing and performance for the specified quarter. While the 8-K itself is brief, it acts as the official channel for disseminating material information regarding Vertex's financial condition, which is crucial for investment decisions. Investors should consider this filing as a notification that updated financial information is available, and direct their attention to the referenced press release for the substantive details.

Key Highlights

  • 1Vertex Pharmaceuticals Inc. reported its consolidated financial results for the quarter ended June 30, 2009, via a press release filed on August 5, 2009.
  • 2This 8-K filing incorporates by reference the press release containing the detailed financial results.
  • 3The press release (Exhibit 99.1) is the primary source for investors to understand Vertex's financial performance for the quarter.
  • 4The information in the press release is not deemed 'filed' for Section 18 liability purposes unless specifically incorporated into a registration statement.
  • 5The filing includes the standard legal disclaimers regarding the information's status under SEC rules.

Frequently Asked Questions

The main purpose of this 8-K filing is to publicly announce and provide access to Vertex Pharmaceuticals' consolidated financial results for the quarter ended June 30, 2009, through the incorporation of a press release issued on August 5, 2009.

The detailed financial results for the quarter ended June 30, 2009, are contained within the press release dated August 5, 2009, which is attached as Exhibit 99.1 to this 8-K filing.

This 8-K filing itself is a notification. The specific financial figures, performance metrics, and any operational updates are detailed in the press release (Exhibit 99.1) that is incorporated by reference.

This is a standard legal disclaimer. It means that while the press release is being submitted to the SEC as part of the filing, the content of the press release itself is not subject to the liability provisions of Section 18 of the Securities Exchange Act of 1934, unless it is explicitly incorporated into a registration statement or other filing where such liability would apply.